Post by
subaru1i on Apr 20, 2024 11:49am
Yet to be made public: 4 new drug approvals for LABS....
2 in Brazil and 2 in the U.S.
CEO said they have 1 approved in Brazil and will make the press release when the 2nd is approved.
Again....JAZZ paid 7.2 billion for a one pony show with GW Pharma and Epidiolex.
4 new drug approvals....has to be worth at least that much or $17.82 per share for LABS, not adusted for inflation either.